Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design
Open accessAbstract
The global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has led to a dramatic loss of human life worldwide. Despite many efforts, the development of effective drugs and vaccines for this novel virus will take considerable time. Artificial intelligence (AI) and machine learning (ML) offer promising solutions that could accelerate the discovery and optimization of new antivirals. Motivated by this, in this paper, we present an extensive survey on the application of AI and ML for combating COVID-19 based on the rapidly emerging literature. Particularly, we point out the challenges and future directions associated with state-of-the-art solutions to effectively control the COVID-19 pandemic. We hope that this review provides researchers with new insights into the ways AI and ML fight and have fought the COVID-19 outbreak.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
ML algorithms have been used to analyze large datasets of potential compounds and identify those with the most potential for treating COVID-19.
“ML algorithms have been used to analyze large datasets of potential compounds and identify those with the most potential for treating the virus.”
From The role of AI in drug discovery: challenges, opportunities, and strategies (2023) · cites this paper as [26]
In some cases, AI-powered approaches have identified promising drug candidates for COVID-19 in a fraction of the time that traditional methods would take.
“In some cases, these AI-powered approaches have been able to identify promising drug candidates in a fraction of the time that it would take when using traditional methods [26,27,28,29,30,31].”
From The role of AI in drug discovery: challenges, opportunities, and strategies (2023) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2 retracted
Zulfiqar, H., Masoud, M. S., Yang, H. Q., et al. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/6683407 · Cited by 16 · see citing works
Self-citationRetractedMedicine, C. A. M. M. I. (2023) · Computational and Mathematical Methods in Medicine · doi:10.1155/2023/9832631 · Cited by 9 · see citing works
RetractedOrigin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,539 · see citing works
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405 · see citing works
Coronavirus Infections—More Than Just the Common Cold
Paules, C. I., Marston, H. D., & Fauci, A. S. (2020) · JAMA · doi:10.1001/jama.2020.0757 · Cited by 2,135 · see citing works
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas
Ren, X., Wen, W., Fan, X., Hou, W., Su, B., Cai, P., Li, J., Liu, Y., Tang, F., Zhang, F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.053 · Cited by 865 · see citing works
Beck, B. R., Shin, B., Choi, Y., Park, S., & Kang, K. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.03.025 · Cited by 815 · see citing works
Emerging Pandemic Diseases: How We Got to COVID-19
Morens, D. M., & Fauci, A. S. (2020) · Cell · doi:10.1016/j.cell.2020.08.021 · Cited by 720 · see citing works
Thomson, E. C., Rosen, L. E., Shepherd, J. G., Spreafico, R., da Silva Filipe, A., Wojcechowskyj, J. A., Davis, C., Piccoli, L., Pascall, D. J., Dillen, J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.037 · Cited by 606 · see citing works
deepDR: a network-based deep learning approach toin silicodrug repositioning
Zeng, X., Zhu, S., Liu, X., Zhou, Y., Nussinov, R., & Cheng, F. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz418 · Cited by 532 · see citing works
Ton, A., Gentile, F., Hsing, M., Ban, F., & Cherkasov, A. R. (2020) · Molecular Informatics · doi:10.1002/minf.202000028 · Cited by 518 · see citing works
COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning
Ong, E., Wong, M. U., Huffman, A., & He, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01581 · Cited by 499 · see citing works
Wei, L., Zhou, C., Chen, H., Song, J., & Su, R. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty451 · Cited by 441 · see citing works
COVID-19 and multiorgan failure: A narrative review on potential mechanisms
Mokhtari, T., Hassani, F., Ghaffari, N., Ebrahimi, B., Yarahmadi, A., & Hassanzadeh, G. (2020) · Journal of Molecular Histology · doi:10.1007/s10735-020-09915-3 · Cited by 440 · see citing works
Target identification among known drugs by deep learning from heterogeneous networks
Zeng, X., Zhu, S., Lu, W., Liu, Z., Huang, J., Zhou, Y., Fang, J., Huang, Y., Guo, H., Li, L., et al. (2020) · Chemical Science · doi:10.1039/c9sc04336e · Cited by 357 · see citing works
Author Correction: A new coronavirus associated with human respiratory disease in China
Wu, F., Su, Z., Yu, B., Chen, Y., Wang, W., Song, Z., Hu, Y., Tao, Z., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2202-3 · Cited by 318 · see citing works
Self-citationMachine intelligence in peptide therapeutics: A next‐generation tool for rapid disease screening
Basith, S., Manavalan, B., Shin, T. H., & Lee, G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21658 · Cited by 311 · see citing works
Ge, Y., Tian, T., Huang, S., Wan, F., Li, J., Li, S., Wang, X., Yang, H., Hong, L., Wu, N., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00568-6 · Cited by 300 · see citing works
An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study
Yang, Z., Bogdan, P., & Nazarian, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-81749-9 · Cited by 271 · see citing works
Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning
Zeng, X., Song, X. H., Ma, T., Pan, X., Zhou, Y., Hou, Y., Zhang, Z., Li, K., Karypis, G., & Cheng, F. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00316 · Cited by 258 · see citing works
Wei, L., Liao, M., Gao, Y., et al. (2013) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2013.146 · Cited by 241 · see citing works
Pham, T.-H., Qiu, Y., Zeng, J., Xie, L., & Zhang, P. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-020-00285-9 · Cited by 219 · see citing works
Hasan, M. M., Schaduangrat, N., Basith, S., Lee, G., Shoombuatong, W., & Manavalan, B. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa160 · Cited by 218 · see citing works
Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov
Zhang, H., Saravanan, K. M., Yang, Y., Hossain, M. T., Li, J., Ren, X., Pan, Y. F., & Wei, Y. (2020) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-020-00376-6 · Cited by 194 · see citing works
Yang, H. Q., Luo, Y., Ren, X., Wu, M., He, X., Peng, B., Deng, K., Yan, D., Tang, H., & Lin, H. (2021) · Information Fusion · doi:10.1016/j.inffus.2021.02.015 · Cited by 192 · see citing works
Charoenkwan, P., Nantasenamat, C., Hasan, M. M., Manavalan, B., & Shoombuatong, W. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab133 · Cited by 181 · see citing works
Wei, L., Chen, H., & Su, R. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.07.004 · Cited by 179 · see citing works
Emerging Pandemic Diseases: How We Got to COVID-19
Morens, D. M., & Fauci, A. S. (2020) · Cell · doi:10.1016/j.cell.2020.10.022 · Cited by 157 · see citing works
AI-Aided Design of Novel Targeted Covalent Inhibitors against SARS-CoV-2
Tang, B., He, F., Liu, D., He, F., Wu, T., Fang, M., Niu, Z., Wu, Z., & Xu, D. H. (2022) · Biomolecules · doi:10.3390/biom12060746 · Cited by 144 · see citing works
StackIL6: a stacking ensemble model for improving the prediction of IL-6 inducing peptides
Charoenkwan, P., Chiangjong, W., Nantasenamat, C., Hasan, M. M., Manavalan, B., & Shoombuatong, W. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab172 · Cited by 134 · see citing works
Wei, L., Hu, J., Li, F., et al. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby107 · Cited by 128 · see citing works
DeepLGP: a novel deep learning method for prioritizing lncRNA target genes
Zhao, T., Hu, Y., Peng, J., et al. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa428 · Cited by 127 · see citing works
<i>De Novo</i> Design of New Chemical Entities for SARS-CoV-2 Using Artificial Intelligence
Bung, N., Krishnan, S. R., Bulusu, G., & Roy, A. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2020-0262 · Cited by 118 · see citing works
Prachař, M., Justesen, S. F. L., Steen-Jensen, D. B., Thorgrimsen, S., Jurgons, E., Winther, O., & Bagger, F. O. (2020) · Scientific Reports · doi:10.1038/s41598-020-77466-4 · Cited by 115 · see citing works
Network medicine framework for identifying drug-repurposing opportunities for COVID-19
Morselli Gysi, D., do Valle, Í., Zitnik, M., Ameli, A., Gan, X., Varol, O., Ghiassian, S. D., Patten, J. J., Davey, R. A., Loscalzo, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025581118 · Cited by 107 · see citing works
Xu, B., Liu, D., Wang, Z., Tian, R., & Zuo, Y. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03594-9 · Cited by 103 · see citing works
Screening of Therapeutic Agents for COVID-19 Using Machine Learning and Ensemble Docking Studies
Batra, R., Chan, H., Kamath, G., Ramprasad, R., Cherukara, M. J., & Sankaranarayanan, S. K. R. S. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c02278 · Cited by 101 · see citing works
Hasan, M. M., Alam, M. A., Shoombuatong, W., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab167 · Cited by 97 · see citing works
Potential T-cell and B-cell Epitopes of 2019-nCoVPreprint
Fast, E., Altman, R. B., & Chen, B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.19.955484 · Cited by 90 · see citing works
Mohapatra, S., Nath, P., Chatterjee, M., Das, N., Kalita, D., Roy, P., & Satapathi, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241543 · Cited by 77 · see citing works
CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative ModelsPreprint
Chenthamarakshan, V., Das, P., Hoffman, S. C., Strobelt, H., Padhi, I., Lim, K. W., Hoover, B., Manica, M., Born, J., Laino, T., et al. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2004.01215 · Cited by 73 · see citing works
Potentially highly potent drugs for 2019-nCoVPreprint
Nguyen, D. D., Gao, K., Chen, J., Wang, R., & Wei, G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.05.936013 · Cited by 61 · see citing works
Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing
Belyaeva, A., Cammarata, L. V., Radhakrishnan, A., Squires, C., Yang, K., Shivashankar, G. V., & Uhler, C. (2021) · Nature Communications · doi:10.1038/s41467-021-21056-z · Cited by 60 · see citing works
A Machine Learning-based Diagnosis of Thyroid Cancer Using Thyroid Nodules Ultrasound Images
Ma, X., Xi, B., Zhang, Y., et al. (2019) · Current Bioinformatics · doi:10.2174/1574893614666191017091959 · Cited by 56 · see citing works
Self-citationA transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2
Wang, S., Sun, Q., Xu, Y., Pei, J., & Lai, L. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab211 · Cited by 52 · see citing works
Karki, N., Verma, N., Trozzi, F., Tao, P., Kraka, E., & Zoltowski, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041573 · Cited by 43 · see citing works
Artificial Intelligence-Guided De Novo Molecular Design Targeting COVID-19
Srinivasan, S., Batra, R., Chan, H., Kamath, G., Cherukara, M. J., & Sankaranarayanan, S. K. R. S. (2021) · ACS Omega · doi:10.1021/acsomega.1c00477 · Cited by 42 · see citing works
Liang, P., Yang, W., Chen, X., Long, C., Zheng, L., Li, H., & Zuo, Y. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.02.004 · Cited by 41 · see citing works
eHSCPr discriminating the cell identity involved in endothelial to hematopoietic transition
Wang, H., Liang, P., Zheng, L., Long, C., Li, H., & Zuo, Y. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab071 · Cited by 40 · see citing works
Long, J., Yang, H. Q., Yang, Z., Jia, Q., Liu, L., Kong, L., Cui, H., Ding, S., Qin, Q., Zhang, N., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.432 · Cited by 40 · see citing works
Li, F., Luo, M., Zhou, W., et al. (2020) · Protein & Cell · doi:10.1007/s13238-020-00807-6 · Cited by 39 · see citing works
Che, M., Yao, K., Che, C., Cao, Z., & Kong, F. (2021) · Future Internet · doi:10.3390/fi13010013 · Cited by 39 · see citing works
Functional alterations caused by mutations reflect evolutionary trends of SARS-CoV-2
Cheng, L., Han, X., Zhu, Z., Qi, C., Wang, P., & Zhang, X. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab042 · Cited by 39 · see citing works
Predicting Drug-target Interactions via FM-DNN Learning
Wang, J., Wang, H., Wang, X., et al. (2019) · Current Bioinformatics · doi:10.2174/1574893614666190227160538 · Cited by 36 · see citing works
Modular arrangements of sequence motifs determine the functional diversity of KDM proteins
Wang, Z., Liu, D., Xu, B., Tian, R., & Zuo, Y. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa215 · Cited by 27 · see citing works
Zhu, J., Deng, Y., Wang, X., Li, X.-F., Zhang, N., Liu, Z., Zhang, B., Qin, C., & Xie, Z. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.02.074021 · Cited by 26 · see citing works
Cancer Diagnosis and Disease Gene Identification via Statistical Machine Learning
Chen, L., Li, J., & Chang, M. (2020) · Current Bioinformatics · doi:10.2174/1574893615666200207094947 · Cited by 25 · see citing works
Identification of Novel Key Targets and Candidate Drugs in Oral Squamous Cell Carcinoma
Liu, J., Lian, X., Liu, F., et al. (2019) · Current Bioinformatics · doi:10.2174/1574893614666191127101836 · Cited by 24 · see citing works
Majumdar, S., Nandi, S. K., Ghosal, S., et al. (2021) · Cognitive Computation · doi:10.1007/s12559-021-09840-x · Cited by 23 · see citing works
A Drug Target Interaction Prediction Based on LINE-RF Learning
Wang, J., Shi, Y., Wang, X., & Chang, H. (2019) · Current Bioinformatics · doi:10.2174/1574893615666191227092453 · Cited by 22 · see citing works
Liu, L., Zhang, L., Dao, F., Yang, Y., & Lin, H. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.11.011 · Cited by 21 · see citing works
Self-citationDrug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence.Preprint
Hsieh, K., Wang, Y., Chen, L., Zhao, Z., Savitz, S. I., Jiang, X., Tang, J. P., & Kim, Y. (2022) · PubMed · Cited by 21 · see citing works
COVID-19 induces lower levels of IL-8, IL-10, and MCP-1 than other acute CRS-inducing diseases
Cheng, L., Zhu, Z., Wang, C., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102960118 · Cited by 21 · see citing works
Research on Gastric Cancer’s Drug-resistant Gene Regulatory Network Model
Li, Z., Zhang, T., Lei, H., et al. (2019) · Current Bioinformatics · doi:10.2174/1574893614666190722102557 · Cited by 18 · see citing works
Liu, L., Li, Q., Jin, W. Y., Lv, H., & Lin, H. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.01.011 · Cited by 17 · see citing works
Self-citationFeasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review
Li, J., Wang, X., Li, N., et al. (2020) · Current Gene Therapy · doi:10.2174/1566523220999200820172829 · Cited by 17 · see citing works
Artificial Intelligence for Bioinformatics and Biomedicine
Zhang, Y. (2020) · Current Bioinformatics · doi:10.2174/157489361508201221092330 · Cited by 8 · see citing works
Self-citationWong, K. K. L. (2019) · Current Bioinformatics · doi:10.2174/157489361405190628122355 · Cited by 7 · see citing works
Transcription-based drug repurposing for COVID-19
Killick, R., Ballard, C. G., Doherty, P., et al. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198176 · Cited by 7 · see citing works
A Mini-review of Computational Approaches to Predict Functions and Findings of Novel Micro Peptides
Nasir, M. A., Nawaz, S., & Huang, J. H. (2020) · Current Bioinformatics · doi:10.2174/1574893615999200811130522 · Cited by 2 · see citing works
RGDtrip: A Database for the Investigation of Proteins Containing the RGD Tripeptide
Hatzis, Y., Thireou, T. N., Viennas, E. S., et al. (2017) · Current Bioinformatics · doi:10.2174/1574893612666170711153356 · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 5
- Chenthamarakshan V, Das P, Padhi I, et al. Mojsilovic AJapa: target-specific and selective drug design for covid-19 using deep generative models. arXiv 2020. https://doi.org/2004.01215.
- Law JN, Akers K, Tasnina N, et al. Murali TJapa: identifying human interactors of SARS-CoV-2 proteins and drug targets for COVID-19 using network-based label propagation. arXiv 2020. https://doi.org/2006.01968.
- Unterthiner T, Mayr A, Klambauer G, Steijaert M, Wegner JK, Ceulemans H, Hochreiter S: Deep learning as an opportu- nity in virtual screening. In: Proceedings of the Deep Learning Workshop at NIPS: 2014; 2014: 1-9.
- Hsieh K, Wang Y, Chen L, et al. Drug repurposing for COVID- 19 using graph neural network with genetic, mechanistic, and epidemiological validation. arXiv 2020. https://doi.org/ 2009.10931.
- Zhavoronkov A, Aladinskiy V, Zhebrak A, et al. Orekhov PJIMHKLA: potential COVID-2019 3C-like protease inhibitors designed using generative deep learning approaches. Insilico Medicine Hong Kong Ltd A 2020;307:E1.
Cited by
Sorted by citations
The role of AI in drug discovery: challenges, opportunities, and strategies
Blanco-González, A., Cabezón, A., Seco-González, A., Conde-Torres, D., Antelo-Riveiro, P., Piñeiro, Á., & Garcia-Fandino, R. (2023) · Pharmaceuticals · doi:10.3390/ph16060891 · Cited by 690 · see citing works
- Authors
- Lv, H., Shi, L., Berkenpas, J. W., Dao, F.-Y., Zulfiqar, H., Ding, H., Zhang, Y., Yang, L., & Cao, R.
- Affiliations
- University of Electronic Science and Technology of China (CN)
- Second Military Medical University (CN)
- Pacific Lutheran University (US)
- Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu 610054, China
- Chengdu University of Traditional Chinese Medicine (CN)
- Harbin Medical University (CN)
- Corresponding author
- Zhang, Yang
- Yang, Liming
- Cao, Renzhi
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-08-18
- Volume
- 22
- Issue
- 6
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- PMC
- PMC8511807
- OpenAlex
- W3193314306
- Cited by
- 107
- References
- 71
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 28 · 2023: 22 · 2022: 29 · 2021: 1
- FWCI
- 10.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Briefings in Bioinformatics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Natural Sciences Undergraduate Research Program at Pacific Lutheran University
- Topics
- Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Keywords
- COVID-19 pandemic, SARS-CoV-2, drug discovery, vaccine design, artificial intelligence, machine learning, pandemic response
- MeSH terms
- Machine Learning, COVID-19, SARS-CoV-2, COVID-19 Vaccines, COVID-19 Drug Treatment, Artificial Intelligence, Humans, Drug Design, Drug Discovery, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review